Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Cigna boosts forecast as lower costs drive profit beat

Published 08/04/2022, 06:12 AM
Updated 08/04/2022, 10:46 AM
© Reuters. FILE PHOTO: A screen displays the logo for Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo

© Reuters. FILE PHOTO: A screen displays the logo for Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo

By Mrinalika Roy and Bhanvi Satija

(Reuters) -Cigna Corp on Thursday raised its annual earnings forecast after topping quarterly profit estimates as a slow recovery in non-urgent procedures lowers medical expenses, sending the insurer's shares up about 5%.

Cigna (NYSE:CI)'s robust performance rounded off a strong quarter for health insurers that have seen their fortunes fluctuate through the pandemic, seesawing between higher COVID-related costs and lower expenses owed to deferred elective procedures.

Lower-than-expected medical utilization within the quarter helped bring down Cigna's medical care ratio (MCR), or the amount spent on medical claims versus the income from premiums, to 80.7% from 84.4% a year earlier.

"Non-COVID costs in the quarter were better than expectations across most service categories, driven by lower levels in inpatient, emergency room care and surgeries and direct COVID costs were also less than projected," Chief Financial Officer Brian Evanko said.

Cigna's quarterly MCR beat was the largest among insurers, Evercore ISI analyst Michael Newshel said in a note.

The Bloomfield, Connecticut-based insurer forecast 2022 MCR between 81.5% and 82.5%, compared with its prior forecast of 82% to 83.5%.

Cigna's health plan customers remained nearly stagnant at 17.8 million compared with the preceding quarter, partly due to weakness in U.S. government-backed Medicare Advantage plans.

Chief Executive Officer David Cordani said the business was running at below target margins, with improvement likely in 2023.

Cigna now expects full-year adjusted earnings of at least $22.90 per share, compared with its previous forecast of $22.60 per share.

© Reuters. FILE PHOTO: A screen displays the logo for Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo

"Though guidance raise appears conservative, Cigna continues to rebound in 2022. We expect additional upside looking toward 2023," Oppenheimer analyst Michael Wiederhorn said.

Excluding special items, Cigna's income from operations was $6.22 per share, above analysts' average estimate of $5.48, according to Refinitiv IBES data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.